4//SEC Filing
Devlin Jodi 4
Accession 0001415889-25-004680
CIK 0001826667other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:37 PM ET
Size
5.3 KB
Accession
0001415889-25-004680
Insider Transaction Report
Form 4
Devlin Jodi
Chief of Clinical Operations
Transactions
- Award
Common Stock
2025-02-18+5,272→ 33,397 total
Footnotes (1)
- [F1]Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 12.5% of the shares subject to the RSU Award shall vest on the grant date of February 18, 2025; 25% of the shares subject to the RSU Award shall vest on each of May 15, 2025, August 15, 2025, and November 14, 2025; and the remaining shares subject to the RSU Award will vest on February 13, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
Documents
Issuer
TriSalus Life Sciences, Inc.
CIK 0001826667
Entity typeother
Related Parties
1- filerCIK 0001992151
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 5:37 PM ET
- Size
- 5.3 KB